Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Translational Oncology|April 4, 2025
Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosisMichael G White, Reed I Ayabe, Mohammad A Zeineddine, et al.
Nature|December 13, 2023
Slide-tags enables single-nucleus barcoding for multimodal spatial genomicsAndrew J C Russell, Jackson A Weir, Naeem M Nadaf, et al.
Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2016
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I TrialRan Xu, Fumiko Shimizu, Koos Hovinga, et al.
Neuro-Oncology|December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-makingMary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed GlioblastomaMary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
The Journal of Clinical Investigation|September 26, 2023
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignanciesStephen Jun Fei Chong, Fen Zhu, Olga Dashevsky, et al.
Science Advances|March 15, 2024
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressivenessXiaodan Qin, Andrew Lam, Xu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse modelsMeenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Pageof 8